287 related articles for article (PubMed ID: 27431483)
1. Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma.
Iyer JG; Blom A; Doumani R; Lewis C; Tarabadkar ES; Anderson A; Ma C; Bestick A; Parvathaneni U; Bhatia S; Nghiem P
Cancer Med; 2016 Sep; 5(9):2294-301. PubMed ID: 27431483
[TBL] [Abstract][Full Text] [Related]
2. Real-world treatment outcomes in patients with metastatic Merkel cell carcinoma treated with chemotherapy in the USA.
Cowey CL; Mahnke L; Espirito J; Helwig C; Oksen D; Bharmal M
Future Oncol; 2017 Aug; 13(19):1699-1710. PubMed ID: 28605939
[TBL] [Abstract][Full Text] [Related]
3. Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma.
Nghiem P; Bhatia S; Lipson EJ; Sharfman WH; Kudchadkar RR; Brohl AS; Friedlander PA; Daud A; Kluger HM; Reddy SA; Boulmay BC; Riker A; Burgess MA; Hanks BA; Olencki T; Kendra K; Church C; Akaike T; Ramchurren N; Shinohara MM; Salim B; Taube JM; Jensen E; Kalabis M; Fling SP; Homet Moreno B; Sharon E; Cheever MA; Topalian SL
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33879601
[TBL] [Abstract][Full Text] [Related]
4. Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial.
Kaufman HL; Russell JS; Hamid O; Bhatia S; Terheyden P; D'Angelo SP; Shih KC; Lebbé C; Milella M; Brownell I; Lewis KD; Lorch JH; von Heydebreck A; Hennessy M; Nghiem P
J Immunother Cancer; 2018 Jan; 6(1):7. PubMed ID: 29347993
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical Trial.
D'Angelo SP; Russell J; Lebbé C; Chmielowski B; Gambichler T; Grob JJ; Kiecker F; Rabinowits G; Terheyden P; Zwiener I; Bajars M; Hennessy M; Kaufman HL
JAMA Oncol; 2018 Sep; 4(9):e180077. PubMed ID: 29566106
[TBL] [Abstract][Full Text] [Related]
6. Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma: a retrospective multicenter DeCOG study.
Stege HM; Haist M; Schultheis S; Fleischer MI; Mohr P; Ugurel S; Terheyden P; Thiem A; Kiecker F; Leiter U; Becker JC; Meissner M; Kleeman J; Pföhler C; Hassel J; Grabbe S; Loquai C
Cancer Immunol Immunother; 2021 Nov; 70(11):3313-3322. PubMed ID: 33870464
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin-based chemotherapy for merkel cell carcinoma of the skin.
Pectasides D; Pectasides M; Psyrri A; Koumarianou A; Xiros N; Pectasides E; Gaglia A; Lianos E; Papaxoinis G; Lampadiari V; Economopoulos T
Cancer Invest; 2006 Dec; 24(8):780-5. PubMed ID: 17162559
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases.
Tai PT; Yu E; Winquist E; Hammond A; Stitt L; Tonita J; Gilchrist J
J Clin Oncol; 2000 Jun; 18(12):2493-9. PubMed ID: 10856110
[TBL] [Abstract][Full Text] [Related]
9. Clinical Benefit from Tyrosine Kinase Inhibitors in Metastatic Merkel Cell Carcinoma: A Case Series of 5 Patients.
Tarabadkar ES; Thomas H; Blom A; Parvathaneni U; Olencki T; Nghiem P; Bhatia S
Am J Case Rep; 2018 Apr; 19():505-511. PubMed ID: 29706615
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma.
Voog E; Biron P; Martin JP; Blay JY
Cancer; 1999 Jun; 85(12):2589-95. PubMed ID: 10375107
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of isolated limb perfusion (ILP) in patients with Merkel cell carcinoma (MCC): A multicenter experience.
van Veenendaal LM; Madu MF; Tesselaar MET; Verhoef C; Grünhagen DJ; van Akkooi ACJ
Eur J Surg Oncol; 2017 Nov; 43(11):2157-2162. PubMed ID: 28802661
[TBL] [Abstract][Full Text] [Related]
12. Avelumab for advanced Merkel cell carcinoma in the Netherlands: a real-world cohort.
Levy S; Aarts MJB; Eskens FALM; Keymeulen KBMI; Been LB; Grünhagen D; van Akkooi A; Jalving M; Tesselaar MET
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32948651
[TBL] [Abstract][Full Text] [Related]
13. Single-fraction radiation therapy in patients with metastatic Merkel cell carcinoma.
Iyer JG; Parvathaneni U; Gooley T; Miller NJ; Markowitz E; Blom A; Lewis CW; Doumani RF; Parvathaneni K; Anderson A; Bestick A; Liao J; Kane G; Bhatia S; Paulson K; Nghiem P
Cancer Med; 2015 Aug; 4(8):1161-70. PubMed ID: 25908228
[TBL] [Abstract][Full Text] [Related]
14. Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma.
Nghiem P; Kaufman HL; Bharmal M; Mahnke L; Phatak H; Becker JC
Future Oncol; 2017 Jun; 13(14):1263-1279. PubMed ID: 28350180
[TBL] [Abstract][Full Text] [Related]
15. Five hundred patients with Merkel cell carcinoma evaluated at a single institution.
Fields RC; Busam KJ; Chou JF; Panageas KS; Pulitzer MP; Allen PJ; Kraus DH; Brady MS; Coit DG
Ann Surg; 2011 Sep; 254(3):465-73; discussion 473-5. PubMed ID: 21865945
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe.
Becker JC; Lorenz E; Ugurel S; Eigentler TK; Kiecker F; Pföhler C; Kellner I; Meier F; Kähler K; Mohr P; Berking C; Haas G; Helwig C; Oksen D; Schadendorf D; Mahnke L; Bharmal M
Oncotarget; 2017 Oct; 8(45):79731-79741. PubMed ID: 29108353
[TBL] [Abstract][Full Text] [Related]
17. Merkel cell carcinoma: report of 10 cases and review of the literature.
Akhtar S; Oza KK; Wright J
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):755-67. PubMed ID: 11050578
[TBL] [Abstract][Full Text] [Related]
18. Merkel cell carcinoma in Turkey: A multicentric study.
Yildiz F; Demirci U; Küçükarda A; Büyüksimsek M; Sakalar T; Topcu TO; Aslan F; Tufan G; Aydin O; Turna H; Babacan NA; Basoglu T; Kurt B; Yildiz B; Eren T; Demiray AG; Gumusay O; Arslan C; Özdemir N; Urun Y; Baykara M; Turan N; Uysal M; Bilici A; Kavgaci H; Çiçin İ; Kilickap S; Paydas S
J Cancer Res Ther; 2021; 17(6):1525-1529. PubMed ID: 34916389
[TBL] [Abstract][Full Text] [Related]
19. Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review study.
Bhatia S; Nghiem P; Veeranki SP; Vanegas A; Lachance K; Tachiki L; Chiu K; Boller E; Bharmal M
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 35981787
[TBL] [Abstract][Full Text] [Related]
20. Merkel cell carcinoma of the eyelid: management and prognosis.
Herbert HM; Sun MT; Selva D; Fernando B; Saleh GM; Beaconsfield M; Collin R; Uddin J; Meligonis G; Leatherbarrow B; Ataullah S; Irion L; McLean CJ; Huilgol SC; Davis G; Sullivan TJ
JAMA Ophthalmol; 2014 Feb; 132(2):197-204. PubMed ID: 24287584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
